Sakar Healthcare

Sakar Healthcare Net Margin

The Net Profit Margin of Sakar Healthcare (SAKAR.NS) as of Nov 5, 2026 is 12.11 %. In the previous year, Net Profit Margin was 9.86 % — a change of 22.87% (higher).

Net Margin

12.11 %

YoY

22.87%

Last updated:

Net Profit Margin of Sakar Healthcare is 2026 12.11 % . Net Profit Margin of Sakar Healthcare was 2025 9.86 % . It decreases by 22.87% higher compared to the previous year.

For Sakar Healthcare, the net margin of 12.1% is broadly stable versus 11.9% a few years ago.

The Sakar Healthcare Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2019
10.27 INR
Jan 1, 2020
11.60 INR
Jan 1, 2021
11.28 INR
Jan 1, 2022
11.89 INR
Jan 1, 2023
9.57 INR
Jan 1, 2024
7.57 INR
Jan 1, 2025
9.86 INR
Jan 1, 2026
12.11 INR
The Sakar Healthcare Net Margin history
YEARNet MarginYoY
12.11 %+22.87%
9.86 %+30.19%
7.57 %-20.87%
9.57 %-19.52%
11.89 %+5.42%
11.28 %-2.77%
11.60 %+12.89%
10.27 %+42.93%
7.19 %-6.03%
7.65 %+42.16%
5.38 %+2.61%
5.24 %-11.16%
5.90 %+8,846.48%
0.07 %+38.57%
0.05 %+39.34%
0.03 %-33.02%
0.05 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Sakar Healthcare Stock analysis

What does Sakar Healthcare do? Sakar Healthcare Ltd. manufactures pharmaceutical products including liquid orals, cephalosporin tablets, capsules, dry powder syrups, dry powder injections, liquid injectables (SVP) in ampoules and vials, lyophilized injections, and oral solid dosages. The company operates as a contract development and manufacturing organization (CDMO) providing these products under brand names such as Oral - Liquid Syrup & Suspension, Liquid Injectable (SVP)-Vials & Ampoules, Cephalosporin - Dry Powder Injections, Cephalosporin - Oral Solid, and Lyophilised Injections (In Vials). Sakar Healthcare serves markets in 14 countries including Uganda, Kenya, Yemen, Ethiopia, Congo, Zimbabwe, Nigeria, Malawi, Philippines, Peru, Vietnam, and Cote D’Ivoire with approximately 321 product registrations. The company generates revenue through the sale of these pharmaceutical products to healthcare providers and distributors in these regions. The firm’s manufacturing unit is accredited by regulatory authorities in 14 countries, which enables it to produce and distribute products across these markets. Sakar Healthcare’s product portfolio includes liquid injectables (SVP) in ampoules and vials, dry powder injections, and oral solid dosages, which are sold to healthcare facilities and pharmacies. The company’s contracts with clients in the pharmaceutical sector involve developing and manufacturing products according to their specifications, with the firm’s focus on cephalosporin-based medications and liquid formulations. Sakar Healthcare Ltd. focuses on providing contract manufacturing services for pharmaceutical products, with a strong emphasis on cephalosporin formulations and liquid-based medications. The company’s products are registered in 321 product registrations across various countries, supporting its operations in 14 regulatory markets. Revenue is derived from the production and sale of these registered products to healthcare providers and distributors in the regions where it holds regulatory accreditation. Sakar Healthcare is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sakar Healthcare stock

Net Profit Margin of Sakar Healthcare is 12.11 % in 2026.

Net Profit Margin of Sakar Healthcare changed from 9.86 % to 12.11 %, representing a 22.87% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Sakar Healthcare since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Sakar Healthcare with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Sakar Healthcare

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Sakar Healthcare